Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (18)

2023

  1. Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 18, pp. 2277-2290

  2. Multivessel spontaneous coronary artery dissection: Clinical features, angiographic findings, management, and outcomes

    International Journal of Cardiology, Vol. 370, pp. 65-71

  3. Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience

    Circulation: Cardiovascular Interventions, Vol. 16, Núm. 3, pp. E012554

2022

  1. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

    The Journal of clinical investigation, Vol. 132, Núm. 21

  2. Clinical Implications of the “Broken Line” Angiographic Pattern in Patients With Spontaneous Coronary Artery Dissection

    American Journal of Cardiology, Vol. 185, pp. 1-9

  3. Clinical outcomes in spontaneous coronary artery dissection

    Heart, Vol. 108, Núm. 19, pp. 1530-1538

  4. Instantaneous Wave-Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations with Fractional Flow Reserve/Intravascular Ultrasound and Prognostic Implications: The iLITRO-EPIC07 Study

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 11, pp. 861-871

2016

  1. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2014

  1. Características y evolución temporal de las citas electrónicas de cuatro de las principales revistas biomédicas Españolas

    Revista Espanola de Cardiologia, Vol. 67, Núm. 10, pp. 837-843

2013

  1. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

    American Heart Journal, Vol. 166, Núm. 4, pp. 669-675

2012

  1. Double antiplatelet therapy after drug-eluting stent implantation: Risk associated with discontinuation within the first year

    Journal of the American College of Cardiology, Vol. 60, Núm. 15, pp. 1333-1339

  2. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490

2010

  1. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation

    Circulation, Vol. 122, Núm. 10, pp. 1017-1025

2008

  1. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies

    Catheterization and Cardiovascular Interventions, Vol. 72, Núm. 4, pp. 459-467

  2. Stent thrombosis in the era of drug-eluting stents

    Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease (CRC Press), pp. 211-219

2006

  1. Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007

  2. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis: Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial

    American Heart Journal, Vol. 151, Núm. 3, pp. 681.e1-681.e9

2003

  1. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis

    Journal of the American College of Cardiology, Vol. 42, Núm. 5, pp. 796-805